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CHAPTER I
INTRODUCTION

Purpose
The Na+/H+ exchanger (NHE) was first studied in renal systems and was thought
to play a role in renal acidification as well as transepithelial water and salt transport. It has
been shown since, however, that the Na+/H+ exchanger (or antiporter) is found not only
in epithelial cells (Grinstein and Rothstein, 1986), but also is found in almost all cells,
displaying a role in key cellular functions such as control of cell volume, regulation of
intracellular pH, and initiation of cell growth and proliferation (Grinstein et al., 1992;
Sardet et al., 1990).
In pH regulation, the antiporter is responsible for allowing one Na+ ion into the
cell for every H+ ion that is released from the cell. It has been demonstrated that a
correlation exists between an increase in intracellular pH (pHj) and an increase in the rate
of protein synthesis in sea urchin eggs (Grainger et al., 1979). It has further been
demonstrated that an increase in pHi plays an important role in the regulation of synthesis
of proteins that are key factors in Xenopus laevis oocyte meiotic maturation (Houle and
Wasserman, 1983). As the pHi increases, the rate of protein synthesis also increases, and
the rate of Xenopus oocyte maturation is dependent on the pHi (Wasserman et al., 1986).
Due to the importance of pHi during oocyte meiotic maturation, the purpose of my study
was to investigate the regulation of the Na+/H+ antiporter in Xenopus laevis oocytes.
My working hypothesis was that the rise in pHi that occurs during oocyte
maturation is the result of the phosphorylation of the Na+/H+ antiporter caused by one or
more protein kinases. During oocyte meiotic maturation, there exists a protein kinase
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cascade, activated by progesterone, which ultimately leads to germinal vesicle breakdown
(GVBD) (Sagata et al., 1989). The following five protein kinases within this cascade were
investigated in this study: c-mos kinase, raf-1 kinase, MAP kinase kinase, MAP kinase,
and S6 kinase. The goal of my study was to determine which one of these protein kinases,
if any, plays a role in the activation of the Na+/H+ antiporter during oocyte maturation. It
has been noted that elevated levels of cAMP block the progesterone-induced increase in
pHi during oocyte meiotic maturation (Rezai, 1994). It is unknown where within the
protein kinase cascade cAMP blocks the increase in pHi. In order to answer these
questions I utilized the following strategies:
1) I attempted to activate the Na+JH+ antiporter by microinjecting one of the
five active protein kinases into Xenopus laevis oocytes.
2) I attempted to determine if this kinase is the only protein that is needed to
activate the antiporter.
3) I attempted to determine where in the kinase cascade cAMP blocks the pHi
increase by artificially altering cAMP levels within the oocyte prior to the
microinjection of each kinase.
4) Propose which of the five kinases, if any, is responsible for the activation
of the Na+JH+ antiporter during Xenopus oocyte maturation.

Literature Review
Oocyte meiotic maturation is the process responsible for preparing the egg for
fertilization (Eckberg, 1988). Oocyte maturation has been studied in a variety of
organisms, both vertebrate and invertebrate, but the most thorough research in this area
has been achieved utilizing the amphibian as a model system (Smith, 1989).
In Xenopus laevis, oogenesis is an asynchronous process having oocytes in
different stages of growth all present in the ovary at the same time. The growth period of
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oocytes has been divided into six stages, I-VI (Dumont, 1972), with stage VI being fullygrown oocytes (1200-1300 µm in diameter). At this final stage, oocytes are arrested in late
G2 phase of meiosis I until they are triggered by hormones to progress to the second
meiotic metaphase, where they are capable of participating in fertilization (Smith, 1989).
Only the stage VI oocytes are capable of responding to hormonal stimulation and resuming
meiosis from prophase arrest (Wasserman et al., 1986).
In vivo, meiotic maturation is initiated by luteinizing hormone (LH), a
gonadotropin released from the anterior pituitary into the circulatory system. Upon
reaching the ovary, LH stimulates the follicle cells surrounding the stage VI oocytes,
causing the follicles to synthesize and release progesterone, a steroid hormone.
Progesterone then acts on the oocytes to induce meiotic resumption (Masui and Markert,
1971). The interaction between progesterone and the oocyte does not follow the typical
steroid-target cell model. In other cell systems, steroids are usually translocated to the
nucleus where they alter specific gene transcription (Beato, 1989). In oocytes,
progesterone acts at the plasma membrane of the oocyte. The signal is then transduced
across the plasma membrane into the cytoplasm of the cell where it is responsible for
triggering a complex series of reactions ultimately leading to meiotic maturation of the
oocyte. Experiments have been performed to confirm that progesterone has to act at the
plasma membrane of the oocyte to induce meiotic maturation, and that progesterone does
not induce maturation from within the cytoplasm of the oocyte. Microinjection of
progesterone into the cytoplasm of stage VI oocytes of Rana pipiens and Xenopus laevis
does not induce meiotic maturation (Masui and Markert, 1971; Wasserman et al., 1986).
Progesterone that is covalently bound to polystyrene beads, so that it cannot pass through
the plasma membrane, is able to induce meiotic maturation when applied to the oocyte
surface (Godeau et al., 1978). Investigators have also identified a steroid receptor on the
plasma membrane of Xenopus laevis oocytes via photoaffinity labeling (Sadler and

4
Maller, 1982; Blondeau and Baulieu, 1984). More recently, the steroid receptors on the
plasma membrane were characterized utilizing radiolabeled progesterone to determine their
binding affinity (Liu and Patino, 1993).
During meiotic maturation, the oocyte nucleus (germinal vesicle, GV) migrates to
the animal pole of the cell, the nuclear envelope undergoes dissolution (germinal vesicle
breakdown, GVBD), the chromosomes condense, the spindle forms, and homologous
chromosomes are segregated. During the migration of the germinal vesicle toward the
animal pole, the pigment granules that are located at the pole are displaced. This
displacement results in the formation of a white spot surrounded by a dark band made up
of the displaced pigment granules, the first visible indication of oocyte maturation.
Concurrent with these morphological events are several physiological events that
take place within the oocyte during meiotic maturation. These events include an increase in
intracellular Ca2+, a decrease in cAMP levels, an increase in intracellular pH, an increase
in protein synthesis, an increase in total protein phosphorylation, and activation of
maturation promoting factor (MPF), a cytoplasmic factor responsible for GVBD and
chromosome condensation (Wasserman and Smith, 1978).
The mechanism by which progesterone activates these morphological and
physiological events that constitute oocyte maturation has been compared to the
transmembrane signalling events of peptide hormones. It is thought that by changing the
intracellular concentrations of second messengers, progesterone indirectly regulates the
intracellular events. Two second messengers, inositol triphosphate (IP3) and 1,2diacylglycerol (DAG), are generated when membrane-bound phosphotidylinositol 4,5bisphosphate (PIP2) undergoes hydrolysis as a result of the activation of phospholipase
C. IP3 triggers the release of Ca2+ from the endoplasmic reticulum, resulting in elevated
levels of Ca2+ which activate calmodulin-dependent kinase (CAM), while DAG is
responsible for activating protein kinase C (PKC) (reviewed by Eckberg, 1988; Smith,
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1989). Cyclic AMP, another second messenger and known regulator of protein kinase A
(PKA), decreases during oocyte maturation. This decrease in cAMP is due to
progesterone inhibition of the cell's adenylate cyclase activity by inhibiting guanine
nucleotide exchange on the associated Gs protein (Sadler and Maller, 1981; Sadler and
Maller, 1983).
One of the physiological events occurring during oocyte maturation is an increase
in intracellular pH (pHi). Studies indicate that the 0.3-0.4 unit increase in pHi may directly
or indirectly be responsible for the increase in the rate of protein synthesis during oocyte
maturation. Stage VI Xenopus laevis oocytes have a pHi of 7 .2-7 .3 and a rate of protein
synthesis of about 20 ng/hr, while mature oocytes have a pHi of 7.6-7.7 and a rate of
protein synthesis of about 40 ng/hr. If a stage VI oocyte is subjected to artificial
alk:alinization, an increase in the rate of protein synthesis occurs (Houle and Wasserman,
1983). These data suggest that pHi is in some way responsible for the regulation of
protein synthesis during maturation of the oocyte.
The regulation of pHi has been investigated in several cell systems where pHi acts
as a regulator for various cellular functions. The one similarity that appears to hold
throughout most of the cell systems is that the increase in pHi seems to be the result of the
stimulation of Na+/H+ antiporters. In Xenopus oocytes, if the extracellular sodium is
replaced with choline chloride, or if amiloride (a Na+/H+ antiporter inhibitor) is used, the
increase in pHi in response to progesterone is completely inhibited (Wasserman and
Houle, 1984; Stith and Maller, 1985; Towle et al., 1991; Rezai, 1994).
In mammalian cell systems, the Na+/H+ antiporter is proposed to be regulated via

a phosphorylation event. It has been suggested that phosphorylation induces a
conformational change within the Na+/H+ antiporter, causing it to acquire an increased
affinity for cytoplasmic H+ (Wakabayashi et al., 1992; Borgese et al., 1992). In support
of this proposal, investigators have demonstrated that concurrent with the increase in
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antiporter activity, there is an increase in the phosphorylation of NHEl (Na+/H+
Exchanger 1), a transmembrane glycoprotein of 110 kDa in fibroblasts, epithelial cells,
and blood platelets (Livne et al., 1991; Sardet et al., 1990; Wakabayashi et al., 1992;
Grinstein et al., 1992; Guizouarn et al., 1993). With the general consensus being that the
Na+/H+ antiporter is activated via phosphorylation, investigations have been performed
using mammalian cell systems to determine which protein kinase(s) is involved in this
event (Guizouarn et al., 1993; Wakabayashi et al., 1992).
In Xenopus oocytes, protein kinases regulated by secondary messengers
following progesterone stimulation were studied and it was found that neither Protein
Kinase C, Protein Kinase A, nor Calcium-Calmodulin Kinase play a role in the activation
of the Na+JH+ antiporter (Rezai, 1994). In addition, maturation promoting factor (MPF)
H-1 kinase, a cytoplasmic kinase which is responsible for GVBD and chromosome
condensation, does not appear to play a role in regulating oocyte pHi (Rezai, 1994).
Another series of kinases within a cascade are known to be activated in response to
progesterone stimulation during oocyte meiotic maturation. This progesterone-induced
kinase cascade is: c-mos kinase ----> raf-1 kinase ----> MAP kinase kinase ----> MAP
kinase----> S6 kinase. I have concentrated on the protein kinases within this cascade to
determine which one, if any, is responsible for activation of the Na+/H+ antiporter in

Xenopus laevis oocytes.
The proto-oncogene protein product p39 c-mos kinase has been proposed to be the
"initiator" of oocyte maturation (Sagata et al., 1989). Within one to two hours following
progesterone stimulation, c-mos kinase is newly synthesized from stored mRNA and
phosphorylated within the oocyte. c-mos kinase mRNA is found in only three types of
tissues in adult Xenopus laevis; brain, testis, and ovary, with the ovary containing the
highest concentrations (Sagata et al., 1988). Within the ovary, c-mos kinase mRNA
expression is restricted to the oocytes, that is the germ line, not the somatic cells. On a per
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oocyte level, the amount of c-mos kinase mRNA remains constant throughout oocyte
growth and maturation, with the protein product appearing only in stage VI oocytes that
have been stimulated by progesterone (Sagata et al., 1988). Injection of either c-mos
kinase mRNA or c-mos kinase protein into stage VI oocytes, in the absence of
progesterone stimulation, was sufficient to induce GVBD. In addition, injection of c-mos
kinase antisense oligonucleotides into stage VI oocytes inhibited progesterone-induced
GVBD (Sagata et al., 1988; Daar et al., 1993). Injection of c-mos kinase protein into
stage VI oocytes that had been pre-treated with cycloheximide (an inhibitor of protein
synthesis) was still capable of initiating GVBD in the absence of progesterone stimulation,
whereas oocytes pre-treated with cycloheximide followed by progesterone treatment did
not undergo GVBD (Yew et al., 1992). These results suggest that c-mos kinase is the
only newly synthesized protein needed to initiate GVBD.
Preliminary experiments have been performed that examined the role of c-mos
kinase in the activation of the Na+JH+ antiporter (Rezai, 1994). A high dose of Maltose
Binding Protein (MBP)-c-mos kinase protein fusion protein was capable of increasing the
intracellular pH of stage VI oocytes that were not treated with progesterone. Since c-mos
kinase rapidly activates other protein kinases within the kinase cascade, however, this
study was unable to conclude if c-mos kinase directly regulates the Na+JH+ antiporter
(Rezai, 1994).
Further observations have been made concerning other protein kinases becoming
phosphorylated and activated following c-mos kinase activation. It has been shown that
MAP kinase (Mitogen Activated Protein kinase formerly known as Microtubule
Associated Protein kinase) becomes activated both in cell-free extracts as well as in fullygrown Xenopus oocytes subsequent to c-mos kinase stimulation, and that active c-mos
kinase is capable of phosphorylating and activating purified MAP kinase kinase in vitro
(Nebreda et al., 1993; Posada et al., 1993). Thus, c-mos kinase is an upstream activator
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of the MAP kinase pathway within the cascade, and may possibly function directly
through the activation of MAP kinase kinase.
The protein kinase that immediately follows c-mos kinase within the cascade has
not been determined at this point, but researchers have found that raf-1 kinase is required
for progesterone-induced oocyte meiotic maturation and that it functions downstream of cmos kinase (Muslin et al., 1993). The gene encoding raf-1 kinase was first isolated from
murine sarcoma retrovirus 3611 (Rapp, 1992). The protein product of the transforming
gene of this retrovirus, v-raf protein, was compared to known amino acids sequences of
tyrosine kinases as well as a phosphoamino acid analysis of the protein product itself,
both results showing that the v-raf protein product is a serine/threonine kinase. Three
genes have since been identified that code for the cellular homologs of v-raf in vertebrates,
c-raf, A-raf, and B-raf. All three are classified as proto-oncogenes in that certain amino
acid sequence mutations can cause oncogenic characteristics. All of the raf-1 proteins
share three highly conserved regions (CRl, CR2, CR3) which make up the primary
structure of these proteins. CR 1, which consists of amino acid residues 62-196, contains
a binding domain for the ras molecule which is followed by a cysteine zinc finger motif.
CR2, consisting of amino acid residues 255-268, is rich in serine and threonine residues
which act as a major phosphorylation site for regulating kinase activity. CR3 consists of
amino acid residues 331-625, is the conserved kinase domain of the protein. The protein
itself can be subdivided into two regions, the regulatory region which consists of CRl and
CR2 at the amino-terminus, and the catalytic region consisting of CR3 at the carboxyterminus. In order for raf-1 kinase to become activated, it has to be phosphorylated on
serine residues, namely Ser43, Ser259, and Ser621 (Morrison et al., 1993). It has been
hypothesized that the regulatory region acts as an autoinhibitor, with the mechanism not
yet fully understood. It has been suggested that the regulatory region folds over the
catalytic region, thereby inhibiting any enzymatic activity. Consistent with this hypothesis
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were the observations from several investigators that excess expression of the regulatory
region of raf-1 kinase blocked the activation of the kinase domain in a dominant negative
manner, and that if the regulatory region in the whole enzyme was mutated or deleted
altogether, a constitutively active raf-1 kinase was produced (Morrison et al., 1993;
Fabian et al., 1993).
In other cell systems, raf-1 kinases are located in the cytoplasm and play an
important role in transmission of signals from cell surface receptors to transcription factors
within the nucleus (Williams and Roberts, 1994). It has been shown that raf-1 kinase
plays a role in the signal cascade shared by epidermal growth factor (EGF) and plateletderived growth factor (PDGF) (Kizaka-Kondoh et al., 1992). The data indicated
biochemical links among activated EGF and PDGF receptors, the p21ras-GTPaseactivating protein mitogenic signalling system, and raf-1 kinase. Ras, like all known
GTP-binding proteins, cycles between an active and inactive form, stimulated by several
extracellular signals. Activated ras appears to act as a regulator of a protein kinase cascade
(Hall, 1994). The following model has been proposed for the role of ras in raf-1 kinase
activation. Activated ras recruits inactive raf-1 kinase to the plasma membrane by binding
to the amino-terminal domain, but ras is not responsible for anchoring raf-1 kinase to the
membrane. Raf-1 kinase appears to be attached to the membrane mainly via membrane
cytoskeletal elements. A ras-independent event occurs by an unknown factor at the
membrane level which unmasks the catalytic domain, which was previously covered by
the amino-terminal regulatory domain, allowing phosphorylation at serine residues 259
and 621, thereby activating raf-1 kinase (Stokoe et al., 1994; Daum et al., 1994; Williams

et al., 1994).
Raf-1 kinase may share common regulatory cofactors with PKC because of the
similarity between amino acid motifs in the regulatory domains of the two kinases. This
appears to be unlikely however, since diacylglycerol and phosphatidylserine, two lipid
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modulators that function as regulatory cofactors for PKC, did not activate purified raf-1
kinase (Bruder and Rapp, unpublished results). Furthermore, it has been stated that
phorbol esters do not bind to the regulatory domain of raf-1 kinase, but bind strongly to
PKC (Bruder and Rapp, unpublished results). Although phorbol esters do not bind raf-1
kinase directly, it has been demonstrated in somatic cells that treatment with the phorbol
ester 12-0-tetradecanoyl-phorbol-13-acetate (TPA, an activator of PKC) does induce
activation of raf-1 kinase. Researchers investigated the possible role of PKCa in the
activation of raf-1 kinase, reaching the conclusion that phosphorylation of Ser499 by
PKCa is essential, and may be a prerequisite for autophosphorylation of Ser259 and

subsequent activation of raf-1 kinase (Kolch et al., 1993).
Based on the results indicating the importance of raf-1 kinase in somatic cell lines,
researchers have speculated that it may play an important role in germ cells as well.
Specifically, researchers are investigating the possible role of raf-1 kinase during
progesterone-induced meiotic maturation in Xenopus oocytes. After progesterone
stimulation, an increase in raf-1 kinase phosphorylation and enzymatic activity was
observed concurrently with an elevation in MAP kinase activity. Upon injection of
mRNA encoding oncogenic raf-1 into nonsteroid-treated oocytes, MAP kinase
phosphorylation, Hl histone phosphorylation, and germinal vesicle breakdown all took
place. When oocytes were injected with a dominant negative mutant of raf-1 to block
endogenous raf-1 kinase activity and then treated with progesterone, none of the events
mentioned above occurred. mRNA encoding c-mos kinase injected into unstimulated
oocytes led to phosphorylation of both raf-1 and MAP kinases. Together, all of these
results lead to the conclusion that raf-1 kinase activity is necessary for progesteroneinduced oocyte meiotic maturation, and that raf-1 kinase is located downstream of c-mos
kinase within the cascade (Muslin et al., 1993; Fabian et al., 1993).
It is believed that the only physiological substrate for active raf-1 kinase is MAP
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kinase kinase. It was shown that MAP kinase kinase was phosphorylated both in vitro as
well as in vivo by raf-1 kinase (Dent et al., 1992; Huang et al., 1993). Unlike most other
kinase interactions, raf-1 kinase seems to form a stable complex with MAP kinase kinase,
with MAP kinase kinase binding to the carboxy-terminal (catalytic) domain of raf-1
kinase. It has been shown that raf-1 kinase activates MAP kinase kinase by
phosphorylating two serine residues, Ser217 and Ser221, within the catalytic domain of
MAP kinase kinase (Alessi et al., 1994). Recently, a group of investigators have shown
that Cdc25 phosphatase, the activator of Maturation Promoting Factor (MPF, a complex
of p34cdc2 kinase and cyclin B), associates with raf-1 kinase in somatic mammalian cells
and in frog meiotic oocytes (Galaktionov et al., 1995). The observed interaction between
Cdc25 and raf-1 kinase occurred at the carboxy-terminal region of raf-1 kinase in vitro,
suggesting a strong and specific interaction between the two proteins.
MAP kinase kinase is a 45 kD protein which was first purified from unfertilized

Xenopus oocytes (Matsuda et al., 1992). It was named MAP kinase kinase for its ability
to induce phosphorylation and activation of inactive MAP kinases in vitro. MAP kinase
kinase is a dual specificity kinase in that it can undergo autophosphorylation on serine,
threonine, and tyrosine residues (Kosako et al., 1992; Nakielny et al.,1992) and
phosphorylate MAP kinase on threonine and tyrosine residues (Crews and Erikson, 1992;
Kosako et al., 1994). No other protein or peptide substrate has yet been identified for
MAP kinase kinase other than p42/p44 MAP kinases (Wu et al., 1993). Recently, an anti-

Xenopus MAP kinase kinase antibody that specifically inhibits Xenopus MAP kinase
kinase activity was produced . Microinjection of this antibody inhibited activation of MAP
kinase by both progesterone stimulation and microinjection of active c-mos kinase in

Xenopus oocytes. It was also observed that in addition to blocking MAP kinase
activation, microinjection of the antibody blocked the activation of MPF as judged by
inhibition of GVBD and histone Hl kinase activation (Kosako et al., 1994). These
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results strengthen the argument that MAP kinase kinase is responsible for activating MAP
kinase in vivo, and acts downstream of c-mos kinase within the cascade.
MAP kinase is a 42kDa serine/threonine protein kinase that is activated in several
cell types under different conditions. These include initiation of intracellular signaling by
receptor tyrosine kinases, protein kinase C, or G proteins, which may activate MAP
kinase by a common pathway, or by pathways that are distinct for each condition (Guan,
1994; Matsuda et al., 1994). Upon stimulation by the above mentioned agents, MAP
kinase becomes phosphorylated on both tyrosine and threonine residues and becomes
activated (Payne et al., 1991). It has further been shown that MAP kinase is activated
during progesterone-induced oocyte meiotic maturation in Xenopus, and that a kinase
activated in response to steroid stimulation is capable of phosphorylating MAP kinase on
tyrosine and threonine residues (Posada and Cooper, 1991). It has been more recently
shown that this dual phosphorylation event is the result of MAP kinase kinase
phosphorylating these tyrosine and threonine residues on MAP kinase (Her et al., 1993).
MAP kinase phosphorylates and regulates numerous cellular signalling proteins. These
include cell surface proteins, cytoskeletal components, cytoplasmic kinases, and nuclear
transcription factors. In X enopus oocytes, MAP kinase is able to phosphorylate
ribosomal S6 kinase II (Sturgill et al., 1988), a protein kinase which will be discussed
later, and microtubule-associated proteins (MAPs) (Shiina et al., 1992). Several
researchers have found protein phosphatases that specifically and efficiently
dephosphorylate, and thereby inactivate, MAP kinases. In vitro, 3CH134, CLlOO, and
HVHl all appear to function as dual specificity tyrosine/threonine phosphatases that are
extremely specific for MAP kinases (Nebreda, 1994; Guan, 1994). Further studies need
to be performed to determine if these phosphatases are responsible for the downregulation of MAP kinases in vivo.
As mentioned previously, one of the physiological substrates for active MAP
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kinase in Xenopus oocytes, as well as in other cells, is ribosomal protein S6 kinase
(Pelech et al., 1993). S6 kinase is a 90 kDa protein kinase which, when activated, is
responsible for the serine phosphorylation of the 40S ribosomal protein S6. Observations
made in various laboratories indicated that a single ribosomal protein (Mr 32,000) became
phosphorylated during meiotic maturation in Xenopus oocytes. This protein was
identified as 40S ribosomal protein S6. It was shown that the level of S6 phosphorylation
increased throughout maturation, when analyzed by two-dimensional polyacrylamide gel
electrophoresis (Nielsen et al., 1982; Kruppa et al., 1983; Wasserman and Houle, 1984).
S6 kinase has been purified fromXenopus oocytes (Erikson and Maller, 1985) and it has
further been shown that S6 kinase has an extreme substrate specificity for S6, the major
phosphoprotein of 40S ribosomal subunits (Erikson and Maller, 1986). Results from
other experiments suggest that the dramatic increase in S6 protein phosphorylation during
oocyte meiotic maturation may not solely be due to an increase in S6 kinase activity. An 810 fold increase in S6 kinase activity does occur, but in conjunction with this increase,
there is also a 50% decrease in S6 phosphatase activity, and possibly an increased
accessibility of the ribosomal substrate to the kinase. All of these changes together may
play a role in phosphorylation of S6 protein in progesterone-induced meiotic maturation in

Xenopus oocytes (Wasserman et al., 1988).
The protein kinase cascade that has been presented is only a partial explanation of
what is occurring within the oocyte during meiotic maturation. Each kinase most likely
phosphorylates other substrates in addition to those protein kinases which are located
directly downstream within the cascade. There also exists the very good possibility that
there are other kinases within this cascade that have not yet been discovered, but may play
an important role during meiotic maturation of the oocyte. With regards to my study, I
have investigated the roles of the five known protein kinases for their possible role in the
regulation of the Na+/H+ antiporter during Xenopus oocyte meiotic maturation. In
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addition, I have also tried to determine the site within the protein kinase cascade where
cAMP blocks the activation of the Na+fH+ anti.porter during oocyte meiotic maturation.

CHAPTER II
MATERIALS AND METHODS

Experimental Desiim
The Na+/H+ exchangers (NHE = Na+/H+ antiporter) in other cell systems appear
to be regulated by phosphorylation of the NHE protein. It has already been shown that
Protein Kinase C, Calcium-Calmodulin Kinase, and Protein Kinase A do not play a role in
activation of the Na+/H+ antiporter in Xenopus oocytes (Rezai, 1994). During oocyte
meiotic maturation, progesterone stimulation activates a cascade of protein kinases (Sagata

et al., 1989). The cascade of protein kinases is as follows. It has been shown that
progesterone stimulation leads to synthesis of c-mos kinase from stored mRNA (Sagata et

al., 1989); c-mos kinase is located upstream of raf-1 kinase within the cascade (Muslin et
al., 1993); raf-1 kinase activates MAP kinase kinase (Huang et al., 1993); MAP kinase
kinase activates MAP kinase (Kosako et al., 1994); MAP kinase activates S6 kinase
(Pelech et al., 1993) (see Figure 1). I have concentrated on these five protein kinases for
their potential role in activating the Na+/H+ antiporter. In Xenopus oocytes, I
hypothesize that one (or more) of these protein kinases activates the Na+/H+ antiporter by
a phosphorylation event.
A) Alternative Hypotheses
Hypothesis I:

c-mos kinase is responsible for activating the Na+/H+
anti.porter via a phosphorylation event.

Hypothesis II:

raf-1 kinase is responsible for activating the Na+/H+ antiporter
via a phosphorylation event
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Figure 1. A proposed model of the progesterone-induced protein kinase cascade which
occurs during Xenopus oocyte maturation. Solid arrows indicate direct activation,
whereas dashed arrows indicate an indirect activation (based on results from other
laboratories).
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Hypothesis III:

MAP kinase kinase is responsible for activating the Na+/H+
anti.porter via a phosphorylation event.

Hypothesis IV:

MAP kinase is responsible for activating the Na+/H+ anti.porter
via a phosphorylation event.

Hypothesis V:

S6 kinase is responsible for activating the Na+/H+ antiporter
via a phosphorylation event.

Hypothesis VI:

An undetermined protein kinase within the cascade is
responsible for activating the Na+/H+ antiporter via a
phosphorylation event.

As there is no antibody available that cross reacts with the Xenopus NHE peptide,
I was not able to directly investigate whether phosphorylation of the antiporter occurs
when oocytes were exposed to various treatments. Therefore, I utilized an indirect
method to observe the involvement of the various protein kinases in regulating the
antiporter. Protein kinases or mRNA encoding these protein kinases were microinjected
into stage VI oocytes and the activity of the Na+/H+ anti.porter (changes in pHi) was
measured. The six possible results are listed below.
B) Potential Outcomes
1) If c-mos kinase, in the absence of progesterone, is capable of activating the
Na+/H+ antiporter without any of the other protein kinases downstream in the
cascade also being able to do so, then Hypothesis I is supported.
2) If raf-1 kinase, in the absence of progesterone, is capable of activating the
Na+/H+ antiporter without any of the other protein kinases downstream in the
cascade also being able to do so, then Hypothesis II is supported.
3) If MAP kinase kinase, in the absence of progesterone, is capable of activating
the Na+fH+ anti.porter without any of the other protein kinases downstream in the
cascade also being able to do so, then Hypothesis III is supported.
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4) If MAP kinase, in the absence of progesterone, is capable of activating the
Na+fH+ antiporter without any of the other protein kinases downstream in the
cascade also being able to do so, then Hypothesis IV is supported.
5) If S6 kinase, in the absence of progesterone, is capable of activating the
Na+/H+ antiporter without any of the other protein kinases downstream in the
cascade also being able to do so, then Hypothesis Vis supported.
6) If all of the above kinases, in the absence of progesterone are not capable of
activating the Na+JH+ antiporter, then Hypothesis VI is supported.

Oocyte Isolation and Culture
Ovarian fragments were surgically removed from adult female Xenopus laevis
(NASCO, Ft. Atkinson, Wisconsin) that had been anesthetized by hypothermia (45
minutes in ice water). The ovarian fragments were then transferred to OR-2 medium
(82.3 mM NaCl, 2.5 mM KCl, 1.0 mM CaCh, 1.0 mM MgCJi, 5.0 mM Hepes, 1.0 mM
Na2HP04, pH 7.6) (Wallace et al., 1973), in which all further procedures were
performed. Full-grown stage VI oocytes (Dumont, 1972) were removed from the ovarian
lobes by manually removing the ovarian epithelium and collagen layer with watchmaker's
forceps, a process known as defolliculation. Collagenase and Pronase were not used to
digest the follicle cells enzymatically to prevent disruption and damage to cell surface
proteins as well as the Na+JH+ antiporter (Towle et al., 1991).

Intracellular pH (pHi) Measurement
The pHi of the oocytes was determined by using the weak acid, 14CDimethyloxazoladine 2,4 dione, 14C-DMO (NEN) (Wadell and Butler, 1959). In its
uncharged form, 14C-DMO can pass freely across the oocyte's plasma membrane. Based
on both the intracellular and extracellular pH environments, a 14C-DMO equilibrium will
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be formed across the membrane of stage VI oocytes in approximately 2 hours (Houle and

Wasserman, 1983) (see Figure 2).
14C-DMO was placed in test tubes at a volume of 2.5 µl per tube (stock 50
µCi/500 µl), which was then dried under N2 to evaporate the ethyl acetate solvent. In
each of the pHi experiments, the 14C-DMO was resuspended in 1.0 ml of either OR-2 or
the desired medium, vortexed, and transferred into 2 ml multiwell plates. The final
concentration of 14C-DMO in each well was 0.25 µCi/ml. Twenty oocytes were placed
into each well per treatment, per experiment. After a minimum of 2.5 hours of incubation
in 14C-DMO at 20° C, drugs or hormones were added and allowed to incubate for the
desired amount of time at 20° C.
Upon completion of the given incubation period, both the media and the oocyte
14C-DMO DPM were determined in triplicate. For the media determination, 10 µl media
from each treatment were transferred into a scintillation vial along with 10 ml
Biodegradable Counting Scintillant (BCS, Amhersham) and mixed thoroughly. For the
oocyte determination, 5 oocytes from each treatment were removed and quickly washed in
3 consecutive dishes containing non-radioactive OR-2 medium (approximately 5-10
seconds per dish). The oocytes were then transferred into scintillation vials where any
excess medium was removed with a pasteur pipette. To each vial was added 0.5 ml NCS11 (tissue solubilizer, Amhersham) before they were placed into a 60° C incubator for 35
minutes where the oocytes were digested. The vials were then placed into a -20° C freezer
for 10 minutes to cool down, after which 10 ml cold BCS-NA (Non-Aqueous
Biodegradable Counting Scintillant, Amhersham) were added to each vial, mixed
thoroughly, and placed into -20° C freezer for another 20 minutes. The media and oocyte
samples were then counted in a Beckman LS-7000 liquid scintillation counter. The CPM
data obtained from the counter was converted to DPM, which was then used to determine
the pHi by utilizing the following formula (Wadell and Butler, 1959):
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pHi = pKa + log ([DMOJinsicte/[DMO]outside (lQpHo-pKa+ 1)-1)

pHi
pKa

= intracellular pH (unknown)

[DMO]inside

=concentration ofDMO inside the oocyte

= pKa of DMO = 6.32
= DPM/µl (water volume of a stage VI oocyte = 0.45 µl)

[DMO]outside

=concentration of DMO outside the oocyte (medium)
=DPM/µl

pHo

= outside pH

=7 .6

There was one basic experimental design that was followed throughout all
experiments that dealt with regulation of pHj. One group of oocytes was left untreated
and served as the negative control group; one group was treated with progesterone and
served as the positive control group; one group of oocytes was microinjected with either
the desired protein kinase or mRNA encoding the desired protein kinase and served as the
experimental group. In addition to examining the pH changes in the oocytes, the oocytes
were also scored for GVBD. All of the experiments were replicated at least three times,
utilizing oocytes from three different animals on three different days.

Protein Kinases and Transcription Vectors
The MBP-c-mos protein fusion protein was obtained from Dr. George F.
VandeWoude. This construct consists of bacterially expressed active c-mos kinase bound
to Maltose Binding Protein (MBP), which is eluted from a Maltose-Sepharose column
with maltose to obtain the purified protein. The protein kinase was in a buffer consisting
of 100 mM NaCl and 20 mM Hepes at a pH of 7.4. The protein concentration of the
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Figure 2. DMO equilibration across the oocyte plasma membrane. Oocytes were
incubated in 14C-DMO (0.25 µCi/ml) for 2.5 hours at 20°C to allow for equilibration. The
equilibrium of DMO across the cell membrane was established according to the
extracellular pH (pHe) and intracellular pH (pHi) environments.
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stock was 0.95 mg/ml, which was diluted with buffer as needed to concentrations of 1.25
ng/40 nl to 40.0 ng/40 nl for microinjection into the oocytes.
MAP kinase kinase was obtained from Dr. Steven Pelech as a bacterial expressed
glutathione synthetase transferase (GST) -fusion protein that was eluted from GSTSepharose beads with glutathione. Three different mutant proteins were received. K97 A
is a kinase-inactive protein by virtue of a lysine to alanine amino acid substitution that is
necessary for ATP binding. S218A/S222A is a regulatory double-mutant which is an
inactive kinase in terms of autophosphorylation and upstream activation. S218E/S222E is
a regulatory double-mutant which is constitutively active and requires no upstream
activation. The preparations were dialysed against the following buffer: 200 mM MOPS,
50 mM EGTA, 20 mM EDTA, 1mMNaC03,10 mM NaF, 240 mM B-glycerophosphate,
and 50 µMB-methyl aspartic acid. The stock concentration of all three protein kinase
preparations was 3 µg per 20 µl.
Active S6 kinase was obtained from Dr. Raymond Erikson as a purified protein
kinase preparation. The concentration of S6 kinase was 1.22 mg/ml in a buffer consisting
of 100 mM NaCl, 20 mM Hepes, pH 7.4, and 1.0 mg/ml BSA. The preparation was
assayed using Xenopus 40s ribosome subunits as substrate.
Transcription vectors with inserts coding three mutants of raf-1 kinase were
obtained from Dr. Deborah K. Morrison. The three transcription vectors coded for: wildtype raf-1 protein (wt-raf-1), which is the full length protein (69 kD) in its
unphosphorylated form; constitutively active raf-1 protein (.1.N'-raf-1 ), which is just the
catalytic region of the protein (40 kD) with the regulatory region removed; kinase deficient
raf-1 protein (KD-raf-1), which is the wt-raf-1 protein (69 kD) with a substitution of
alanine for serine at position 621 rendering it incapable of kinase activity. The expected
sizes of the three mRNAs was as follows: wt-raf-1
kilobases, and KD-raf-1

= 2.2 kilobases.

= 2.2 kilobases,

.1.N'-raf-1

= 1.3
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Transcription of Plasmid Vectors
1. Linearization of Plasmids. Each of the plasmids had to be linearized before it
could be transcribed into mRNA. All of the plasmids were cut with the restriction enzyme
EcoR I since there was only one EcoR I restriction site in the plasmid, located downstream
of the insert. The following protocol was utilized for all of the plasmids. Into a RNasefree eppendorf tube was added 0.5 µI plasmid solution (approximately 2.0 µg DNA), 2.0
µl lOx EcoR I Buffer (NEBuffer System, BioLabs, New England), 1.0 µl EcoR I (20
Units/µ!) (BioLabs, New England), and 16.5 µl RNase-free H10. The solutions were
placed into a 37° C waterbath for one hour, after which time a 2 µI aliquot was removed
from each reaction tube and run on a gel to verify proper digestion of the plasmids. The
remainder of the reaction mixture was precipitated with 1.8 µl 5 M ammonium acetate and
36 µl 100% ethanol at -20° C. To the 2 µl aliquots were added 3 µl 6x loading buffer
(0.25% Bromophenol blue, 10 mM Tris-HCl pH 8.0, 1mMEDTA,30% glycerol, dH20
to 50 ml) and 13 µI RNase-free H20. All samples were heated for ten minutes at 65° C
and run on an 0.8% agarose gel at 100 volts for 45 minutes. The gel was then stained for
15 minutes with Ethidium Bromide (EtBr, 0.5 µg/ml), rinsed with RNase-free H10, and
viewed under an ultraviolet light source comparing the bands of linearized DNA to known
lambda DNA markers (GIBCO/BRL) run in adjoining lanes.
2. Transcription of the linearized DNA. The linearized plasmids were centrifuged
at 12,500 x g for 20 minutes, the supernatant was removed, and the pellets were
desiccated and resuspended in TE Buffer (10 mM Tris-HCI, 1.0 mM EDTA, pH 8.0).
The linearized plasmids were transcribed using an in vitro SP6 polymerase transcription
kit (mMESSAGE mMACHINE Kit, Ambion, Inc.) following the protocol supplied with
the kit, with the termination step being the following protocol for mRNA purification
rather than the procedures suggested in the kit. To purify the mRNA that was transcribed,
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the RNeasy Total RNA Kit following the RNeasy Clean-up Protocol (Qiagen, Inc.) was
used. The final product was suspended in RNase-free H20. Two separate methods were
used to determine if the transcription reaction had worked successfully. First, the
concentration of the mRNA transcribed was determined. Two µl sample were added to 1
ml RNase-free H20 and the absorbance (A260/ A2so) readings were taken with a
spectrophotometer. Second, aliquots of the samples were run on an agarose gel to
determine if the proper size mRN A was transcribed. All samples were first denatured in
the following solution: 4.7 µI mRNA (2 µg). 2.0 µl 5x MOPS, 3.3 µl formaldehyde,
10.0 µl formamide, and 1.5 µl EtBr (stock

= 10 mg/ml) for

15 minutes at 55° C, after

which 5 µl of 6x loading buffer (same buffer as was used in DNA agarose gels) was
added. The samples were then run on a 1.0% agarose gel containing lx MOPS and 0.67
M formaldehyde at 70 volts for 45 minutes. The gel was then thoroughly rinsed with
RNase-free H20 (approximately 30 minutes, changing it periodically) and viewed on an
ultraviolet light source. The sizes of the transcripts were compared to RNA markers
(Promega) run in adjoining lanes.

Microinjection of Protein Kinases and mRNA
Throughout my study, I used either protein kinases or mRNA encoding protein
kinases that would not readily pass across the plasma membrane of the oocyte and
therefore had to be microinjected directly into the oocyte cytoplasm. Microinjection
needles were made from 10 mm x 100 mm glass capillary tubes using a De-Fonbrune
microforge, and were designed to deliver 1.25 ng to 40.0 ng per 40 nl per oocyte. This
delivery was made into a single site within each oocyte's cytoplasm. A Brinkman
micromanipulator was used to guide the injection needles.
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Electrophoretic Analysis of Raf-1 Protein Products
To examine the raf-1 kinase proteins synthesized in mRNA-injected oocytes, 10
stage VI oocytes were left untreated, treated with progesterone (1 µM, Sigma), or
microinjected with mRNA for the three forms of raf-1 kinase and allowed to incubate for 6
hours at 20° C. The oocytes were then labelled in 35S-methionine at 50 µCi/ml for 1 hour
at 20° C. After the 1 hour of labelling, 6 oocytes from each treatment group were
homogenized in 1.0 ml protein extraction homogenization buffer (100 mM NaCl, 20 mM
Tris-HCl, 10 mM B-mercaptoethanol, 0.5 mM phenylmethylsulfonyl fluoride) and
centrifuged for 10 minutes at 12,500 x g. After centrifugation, 0.5 ml supernatant was
drawn off and added to 1.0 ml 100% ethanol and stored at -20° C for a minimum of 8
hours to precipitate proteins.
The precipitates were then centrifuged for 20 minutes at 12,500 x g, the
supernatant was removed, and the protein pellets were dried for 1 hour under vaccum.
The pellets were resuspended in 50 µl SDS sample buffer (Tris, pH 6.8, glycerol,
bromphenol blue, B-mercaptoethanol, sodium dodecyl sulfate, and dH20), boiled, and
then loaded onto a 10% Laemmli gel (1970). After running at 25 milliamps for 3.5 hours,
the gel was stained with Coomassie Blue to confirm that equal amounts of protein were
present in each lane. The gel was then subjected to flurography with 2,5-Diphenyloxazole
(PPO) and glacial acetic acid, dried for 2 hours at 80° C, and put up with XAR-5 film
(Kodak) and stored at -85° C for 3 days. After film development, the newly synthesized
raf-1 kinase protein bands were compared to 14C-marker proteins (Amersham) that were
run in separate lanes.

Dose Response Curves for Protein Kinases or mRNA
Preliminary experiments consisted of microinjecting the stock concentration of the
protein or mRNA into stage VI oocytes and determining if a statistically significant
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increase in pHi had occurred compared to control and progesterone-treated oocytes. All
preliminary experiments were replicated at least three times for each protein or mRNA. If
a significant increase in pHi was observed, the following experiments were carried out
Groups of 20 stage VI oocytes were microinjected with different doses of the
protein kinase or mRNA ranging from 1.25 ng to 40.0 ng per oocyte and were incubated
in OR-2 media containing 14C-DMO at 20° C for the times indicated in the text. After this
incubation period, the oocyte pHi was determined for the various doses and compared to
the pHi in control and progesterone-treated oocytes. The lowest dose of protein or
mRNA which gave a pHi increase that was statistically similar to the pHi of progesteronetreated oocytes was used in all subsequent experiments .

Protein Synthesis Requirement for Antiporter Activation
It has been shown that protein synthesis is necessary for GVBD to occur in

response to progesterone treatment (Wasserman and Masui, 1975). It has also been
shown that a new protein(s) has to be synthesized in order to activate the Na+/H+
antiporter in response to progesterone stimulation (Rezai, 1994). It is known that c-mos
kinase is newly synthesized upon hormonal stimulation (Sagata et al., 1989), but is c-mos
kinase the only newly synthesized protein needed to activate the Na+JH+ anti.porter?
Groups of 20 stage VI oocytes were preincubated in OR-2 medium containing
14C-DMO with or without cycloheximide (10 µg/ml, Sigma), a specific inhibitor of
protein synthesis for 12 to 14 hours. This concentration of cycloheximide has been
shown to inhibit protein synthesis by 98% (Wasserman et al., 1986). The oocytes were
then either left untreated, treated with progesterone (1 µM, Sigma), or microinjected with
a particular protein kinase and allowed to incubate at 20° C for 8 to 12 hours. After this
incubation period, the oocyte pHi was determined for all treatment groups. The proteinmicroinjected groups were compared to the control and progesterone-treated groups in the
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absence or presence of cycloheximide.

The Effect of cAMP on Antiporter Activation
It has been shown that progesterone has an inhibitory effect on adenylate cyclase

inXenopus oocytes causing a decrease in oocyte cAMP levels (Maller and Krebs, 1977;
Schorderet-Slatkine et al., 1982; Matten et al., 1994). It has also been shown that if
intracellular cAMP concentrations remain elevated, progesterone-induced GVBD will not
occur (Schorderet-Slatkine et al., 198 2). Recent studies by Rezai ( 1994) have indicated
that elevated levels of cAMP are also antagonistic toward progesterone-induced activation
of the Na+JH+ antiporter. My goal was to determine at what point within the protein
kinase cascade elevated levels of intracellular cAMP inhibit activation of the Na+/H+
antiporter. Previous studies have shown that there are at least two different experimental
methods of altering cAMP levels in Xenopus oocytes: forskolin, an activator of adenylate
cyclase; and 8-Bromo-adenosine-3':5'-monophosphate, cyclic (8-Br-cAMP), a cellpermeable cAMP analogue.
1. Forskolin. Groups of 20 stage VI oocytes were preincubated in OR-2 medium
containing 14C-DMO with or without forskolin (100 µM, Calbiochem) for 8 to 14 hours
at 20° C. This concentration of forskolin as well as the incubation period were selected
based on previous studies (Rezai, 1994). The oocytes were then either left untreated,
treated with progesterone (1 µM, Sigma), or rnicroinjected with a particular protein kinase
or mRNA and allowed to incubate at 20° C for the times indicated in the text. After this
incubation period, the oocyte pHi was determined for all treatment groups.
2. 8-Br-cAMP. Groups of 20 stage VI oocytes were preincubated in OR-2
medium containing 14C-DMO with or without 8-Br-cAMP (1.0 mM, Boehringer
Mannheim) for 8 to 14 hours at 20· C. This concentration of 8-Br-cAMP was selected
based on other studies (Nagasaka et al., 1994). The oocytes were then either left
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untreated, treated with progesterone (1 µM, Sigma), or rnicroinjected with a particular
protein kinase or mRNA and allowed to incubate at 20° C for the times indicated in the
text. After this incubation period, the oocyte pHi was determined for all treatment groups.

Electrophoretic Analysis of S6 Phosphorylation in MAP Kinase Kinase or S6 Kinase
Injected Oocytes
To verify that active MAP kinase kinase and S6 kinase were being rnicroinjected
into the oocytes, the phosphorylation of the S6 protein on the 40s ribosomal subunit was
monitored since the cascade follows from MAP kinase kinase to MAP kinase to S6 kinase
to the phosphorylation of the S6 protein.

To examine ribosomal S6 protein

phosphorylation, 10 stage VI oocytes were left untreated, treated with progesterone (1
µM, Sigma), or rnicroinjected with MAP kinase kinase (which was concentrated 3-fold
with centricon 30 microconcentrators, Micon) or S6 kinase, labelled in 32p_
orthophosphate at 50 µCi/ ml for 8 to 12 hours at 20° C. After this incubation, oocytes
were homogenized, protein was extracted and precipitated as mentioned previously. The
precipitated proteins were resuspended and run on a gel, checked for equal loading of
proteins, and dried as described above without flurography. The dried gel, XAR-5 film
(Kodak), and an intensification screen were then stored at -85° C for 3 days. After film
development, the phosphorylated ribosomal S6 protein bands were compared in the
various treatment groups.

Statistical Analysis
In each experiment, three groups of five oocytes each (15 oocytes total) were used
to measure the intracellular pH of the oocyte in triplicate. All experiments were replicated
using oocytes from a minimum of three different animals on three different days (n = 3).
All intracellular pH values are the mean pHi value ±the standard error of the mean. The
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data were analyzed by two-way analysis of variance (ANOV A), and when a significant Fvalue was encountered, the different treatments were compared using the Tukey's multiple
comparisons test. The data were analyzed using MYSTAT and SYSTAT statistical
programs.

CHAPTER III
RESULTS

The order of the following experiments reflects the order in which the various
protein kinases were received from other Laboratories.

Part I: c-mos kinase
The first protein kinase to be investigated in this study was c-mos kinase. A
previous study from our laboratory has implicated c-mos kinase in activation of the
Na+/H+ antiporter in Xenopus oocytes during meiotic maturation (Rezai, 1994).
Preliminary results using high doses of kinase microinjected into oocytes indicated that
either c-mos kinase, or some protein kinase downstream of c-mos kinase played a role in
the activation of the Na+/H+ antiporter. The focus of my initial experiments was to
confirm the role of c-mos kinase in regulation of oocyte pHi during progesterone-induced
meiotic maturation.
A. c-mos kinase Dose Response Curve:

Injecting 20 ng c-mos protein per oocyte induced an increase in oocyte pHi that
was statistically similar to the increase in pHi caused by progesterone (Rezai, 1994). To
determine the lowest concentration of c-mos protein needed to cause an increase in oocyte
pHi that was similar to the increase in pHi caused by progesterone, oocytes were injected
with different concentrations of c-mos protein. As shown in Figure 3, oocytes were
microinjected with concentrations of c-mos kinase ranging from 1.25 ng to 40.0 ng per
oocyte. Increasing concentrations of c-mos kinase induced an increase in pHi,

30

31

7.9
7.8

b

7.7
7.6

:::c

c.

7.5
7.4
7.3
7.2
cont

prog

1.25

2.5
5.0
20.0
c-mos (ng/oocyte)

40.0

Figure 3. c-mos kinase dose response curve. Oocytes were either left untreated (cont),
treated with progesterone (1 µM), or microinjected with concentrations of c-mos kinase
ranging from 1.25 to 40.0 ng of protein per oocyte. At concentrations of 5.0 ng per
oocyte and higher, the increase in pHi was statistically similar to the increase in pHi
induced by progesterone. All subsequent experiments used 5.0 ng of c-mos protein per
oocyte. Columns with different letters above them are significantly different from each
other using Tukey's multiple test comparison. The data are expressed as means ± the
standard error of the mean, where n=3.
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which appeared to level off at concentrations greater than 5.0 ng protein per oocyte. 5.0
ng c-mos protein was the lowest concentration that caused an increase in oocyte pHi
statistically similar to the increase in oocyte pHi induced by progesterone. All subsequent
experiments used 5.0 ng c-mos protein per oocyte.
B. Protein Synthesis ReQllirement for N ~ Antiporter Activation:
It has been shown that oocyte protein synthesis is required for activation of the

Na+fH+ antiporter in response to progesterone stimulation (Rezai, 1994). It is known that
c-mos kinase is newly synthesized upon hormonal stimulation (Sagata et al., 1989). To
determine if c-mos kinase is the only newly synthesized protein required for the activation
the Na+JH+ antiporter during oocyte meiotic maturation, the following experiment was
performed. Oocytes were treated either with 10 µg/ml cycloheximide (a specific inhibitor
of protein synthesis, at a concentration which has been shown to inhibit protein synthesis
by 98%, Wasserman et al., 1986) and 14C-DMO or just with 14C-DMO for 12 to 14
hours. As shown in Figure 4, oocytes from each of the two groups were either left
untreated (Cont), treated with progesterone (1 µM), or microinjected with c-mos protein
(5 ng/oocyte). The results showed that the pHi in steroid-stimulated oocytes treated with
cycloheximide remained at levels that were statistically similar to the pHi of both control
oocytes with or without cycloheximide. The results showed that the pHi of oocytes
microinjected with c-mos protein, even in the presence of cycloheximide, was statistically
similar to the pHi of progesterone-stimulated oocytes. Thus, c-mos kinase appears to be
the only newly synthesized protein needed for the activation of the Na+fH+ antiporter
during oocyte meiotic maturation.
C. cAMP Block of Antiporrer Activation:
Progesterone has been shown to have an inhibitory effect on adenylate cyclase in
Xenopus oocytes causing a decrease in oocyte cAMP levels (Sadler and Maller, 1981).
Not only has it been demonstrated that eleYated cAMP concentrations within the oocyte
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Figure 4. c-mos kinase is the only newly synthesized protein needed for activation of the
Na+/H+ antiporter. Oocytes were incubated in 14C-DMO for 12 to 14 hours in the presence
or absence of cycloheximide (10 µg/ml). The oocytes from both groups were the either left
untreated (Cont.), treated with progesterone ( 1 µM), or microinjected with c-mos kinase
(5.0 ng/oocyte). The pHi of oocytes nTicroinjected with c-mos kinase, both treated and not
treated with cycloheximide, was statistically similar to the pHi of progesterone-treated
oocytes that had not been treated with cycloheximide. Columns with different letters above
them are significantly different from each other using Tukey's multiple comparison test.
The data are expressed as means ± the standard error of the mean, where n=3.
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inhibit GVBD (Schorderet-Slatk:ine et al., 1982), but a recent study from our laboratory
has indicated that elevated levels of cAMP are also antagonistic toward progesteroneinduced activation of the Na+JH+ antiporter during oocyte meiotic maturation (Rezai,
1994). To determine if elevated levels of intracellular cAMP are antagonistic toward cmos kinase-induced activation of the Na+/H+ antiporter, the following two methods of
altering cAMP levels in Xenopus oocytes where used.
1. Forskolin Activation of Acienylate Cyclase:
The first method used was incubating the oocytes in forskolin, an activator of
adenylate cyclase, to elevate the levels of intracellular cAMP. Oocytes were treated either
with forskolin (100 µM) at a concentration shown to have an inhibitory effect on the
progesterone-induced increase in pHi (Rezai, 1994) in 14C-DMO, or just with 14C-DMO
for 12 to 14 hours. Oocytes from each of the two groups were left untreated (Cont.),
treated with progesterone (1 µM), or microinjected with c-mos protein (5 ng/oocyte). As
shown in Figure 5, forskolin inhibited the increase in pHi in progesterone-stimulated
oocytes to a level that was statistically similar to control pHi levels. Forskolin did not
appear to be antagonistic to c-mos kinase's ability to activate the Na+JH+ antiporter. The
pHiS in c-mos kinase-injected oocytes with or without forskolin pretreatment were
statistically similar.
2. 8-Br-cAMP Elevation of Intracellular cAMP Levels:
To verify the forskolin results, a second method of elevating levels of intracellular
cAMP was utilized. 8-Br-cAMP (8-Bromo-adenosine-3':5'-monophosphate, cyclic) is a
cAMP derivative capable of passing through the oocyte's membrane into the cytoplasm,
thus causing an elevation in intracellular cAMP levels. Oocytes were treated with 8-BrcAMP (1.0 mM) in 14C-DMO or just with 14C-DMO for 12 to 14 hours. Oocytes from
each of the two groups were either left untreated (Cont.), treated with progesterone (1
µM), or microinjected with c-mos protein (5 ng/oocyte).

As shownin Figure 6,
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Figure 5. Forskolin does not appear to be antagonistic to c-mos kinase's ability to activate
the Na+/H+ antiporter. Oocytes were incubated in 14C-DMO for 12 to 14 hours in the
presence or absence of forskolin (100 µM). The oocytes from both groups were then
either left untreated (Cont.), treated with progesterone (1 µM), or microinjected with cmos kinase (5.0 ng/oocyte). The pHi of the oocytes microinjected with c-mos did not
differ significantly regardless if treated with forskolin or not. Columns with different
letters above them are significantly different from each other using Tukey's multiple
comparison test. The data are expressed as means± the standard error of the mean, where

n=4.
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8-Br-cAMP was antagonistic to progesterone's ability to cause an increase in pHi,
maintaining pHi at levels statistically similar to the control pHi values. The results with cmos kinase and 8-Br-cAMP confirmed the results of the forskolin experiment. Oocytes
injected with c-mos kinase and treated with 8-Br-cAMP maintained levels of elevated pHi
that were statistically similar to the group of oocytes that was just stimulated with
progesterone. The results from both the forskolin experiments and the 8-Br-cAMP
experiments showed that elevated levels of intracellular cAMP were antagonistic toward a
progesterone-induced increase in pHi but have no effect on the ability of c-mos kinase to
cause an increase in pHi. This indicates that the cAMP block is downstream of the
progesterone receptor, but upstream of c-mos kinase in the protein kinase cascade.

Part II: S6 kinase
S6 kinase was the next protein kinase investigated. S6 kinase, when activated, is
responsible for phosphorylating the 40S ribosomal protein S6. S6 kinase is one of the
terminal kinases, located directly downstream of MAP kinase. It has further been shown
that the substrate of S6 kinase, 40S ribosomal protein S6, becomes phosphorylated during
oocyte meiotic maturation. I therefore wanted to investigate if S6 kinase, in addition to
phosphorylating the ribosomal protein, was involved in regulation of the Na+/H+
antiporter during oocyte meiotic maturation.

A. S6 kinase Effect on pHj;
To determine if S6 kinase is involved in activating the Na+fH+ antiporter, groups
of oocytes were preincubated in 14C-DMO for 12 to 14 hours, and then were either left
untreated (Cont.), treated with progesterone (1 µM). or microinjected with active S6
kinase (50 ng/oocyte). As shown in Figure 7, oocytes injected with active S6 kinase did
not exhibit an increase in pHi. Oocytes injected with S6 kinase maintained pHi levels that
were statistically similar to those in untreated oocytes.
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Figure 6. Elevating intracellular levels of cAMP with 8-Br-cAMP does not appear to be
antagonistic to c-mos kinase's ability to activate the Na+/H+ antiporter. Oocytes were
incubated in 14C-DMO for 12 to 14 hours in the presence or absence of 8-Br-cAMP (1.0
mM). The oocytes from both groups were then either left untreated (Cont.), treated with

progesterone (1 µM), or microinjected with c-mos kinase (5.0 ng/oocyte). The pHi of
oocytes microinjected with c-mos kinase, both treated and not treated with 8-Br-cAMP,
were statistically similar to one another, as well as to the pHi of progesterone-treated
oocytes not treated with 8-Br-cAMP. Columns with different letters above them are
significantly different from each other using Tukey's multiple comparison test. The data
are expressed as means± the standard error of the mean, where n=3.
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Figure 7. S6 kinase does not activate the Na+/H+ antiporter. Oocytes were incubated in
14C-DMO for 12 to 14 hours and were then either left untreated (Cont.), treated with
progesterone (1 µM), or microinjected with S6 kinase (50 ngloocyte). The pHi of the
oocytes microinjected with S6 kinase was statistically different from the pHi of the
progesterone-treated oocytes, but statistically similar to the pHi of oocytes that were left
untreated (Cont.). Columns with different letters above them are significantly different
from each other using Tukey's multiple comparison test The data are presented as means

± the standard error of the mean, where n=4.
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B. Electrophoretic Analysis of S6 Phosphorylation:
The above result indicated that S6 kinase does not play a role in regulating pHi.
To verify that the injected S6 kinase was active, phosphorylation of S6 protein in the
injected oocyte ribosomal subunits was monitored. Oocytes were either left untreated
(Cont.), stimulated with progesterone (l µM), or microinjected with S6 kinase and
labelled in OR-2 medium with 32P-orthophosphate (100 µCi/ml) for 8 hours. Oocytes
were removed from their respective treatments and proteins were extracted and
electrophoresed using a SDS-polyacrylamide gel (SDS-PAGE). Figure 8 shows an
autoradiograph comparing the phosphorylation of S6 protein between the three treatments.
S6 protein has a molecular weight of 32,000. Based on this experiment, S6 protein
(32,000 Da) was phosphorylated in the progesterone-stimulated oocytes as well as in the
S6 kinase-microinjected oocytes, but not in the untreated oocytes. This indicates that the
S6 kinase that was used in previous experiments was active and that the negative effect of
S6 kinase on oocyte pHi was valid.

Part III: raf-1 kinase
I was unable to obtain raf-1 kinase protein, but rather, received transcription
vectors with inserts coding for three forms of raf-1 kinase. The three transcription vectors
coded for: l) wild-type raf-1 protein (wt-raf-1), the full length protein in its
unphosphorylated form; 2) constitutively active raf-1 protein (~'-raf-1 ), just the catalytic
region of the protein with the regulatory region removed; 3) kinase deficient raf-1 protein
(KD-raf-1), the wt-raf-1 protein with an alanine for serine substitution at position 621
rendering it incapable of kinase activity (Fabian et al., 1993).
A. Transcription of Plasmid Vectors and Translation of mRNA for raf-1:
1. Linearization of raf-1 Plasmids:
Each of the three plasmids was first linearized before it could be transcribed into
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Figure 8. S6 kinase phosphorylates the S6 protein when injected into oocytes. Oocytes
were left either untreated (lane 1), treated with progesterone (1 µM) (lane 2), or
microinjected with S6 kinase (lane 3) and labelled in OR-2 medium with 32p_
orthophosphate (100 µCi/ml) for 8 hours. Protein was extracted from each of the
treatment groups and run on a 10% SDS-polyacrylamide gel. Phosphorylation of the S6
protein (32,000 Da) was observed in both the progesterone-treated oocytes, as well as in
the S6 kinase microinjected oocytes, but not in the untreated oocytes as compared with
14C-methylated protein markers (lane not shown).
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mRNA. The plasmids were cut with the restriction enzyme EcoR I. There was only one
EcoR I restriction site in each of the plasmids, located not too far downstream of the
inserts. After the digest, a sample of each DNA product was electrophoresed on a 0.8%
agarose gel to verify that the plasmids were cut only once, and that the linearized
fragments were of the proper length. Figure 9 is a photograph of an ethidium bromidestained agarose gel which has alternating lanes of uncut and cut plasmids. Lanes at both
ends of the gel are lambda DNA markers. As seen in figure 9, the uncut plasmid existed
as both a supercoiled and a relaxed form, while the digest produced a single DNA
fragment of 4.8, 4.8, and 4.3 kilobases in length for wt-raf-1, KD-raf-1 and iiN'-raf-1
respectively.

2. Transcription of the Linearized raf-1 DNA:
The linearized DNA for all three plasmids was transcribed using an in vitro SP6
polymerase transcription kit (Ambion). In order to purify the transcribed mRNA, RNeasy
centrifuge columns were used and the final product was suspended in RNase-free H20.
To ensure that the transcription product mRNA was of the proper length, 2.0 µg of each
mRNA sample was run on a 1.0% agarose denaturing gel. Figure 10 shows a photograph
of an ethidium bromide-stained gel with two lanes of each mRNA sample flanked by
known RNA markers. As seen in figure 10, the sizes of the transcribed mRNA were 2.2
kilobases for the wt-raf-1 and KD-raf-1 mRNAs, and 1.7 kilobases for the iiN'-raf-1
mRNA coding just for the catalytic region of the protein. These transcript sizes agree with
published values.
3. Electrophoretic Analysis of raf-1 mRNA Translation Products:
The transcribed mRNA coding for the three forms of raf-1 kinase were
microinjected into different groups of oocytes. H the oocytes were capable of translating
the mRNA, then the possible effects of these protein products on pHi could be monitored
after microinjecting the mRNA samples. To confirm that the microinjected mRNAs were

42

1

2

3

4

5

6

7

8

Figure 9. Linearization of raf-1 DNA plasmids. Each of three plasmids were cut with
the restriction enzyme EcoR I to linearize them for transcription. Samples from each
digest were run on a 0.8% agarose gel and stained with ethidium bromide. Lanes 1 and
8: lambda DNA markers; lane 2: uncut wt-raf-1; lane 3: cut wt-raf-1; lane 4: uncut ~N'
raf-1; lane 5: cut ~'-raf-1; lane 6: uncut KD-raf-1; lane 7: cut KD-raf-1. The two bands
appearing in all of the uncut lanes represent both the supercoiled (lower band) and relaxed
(upper band) forms of the plasmid.
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Figure 10. Transcription of the linearized raf-1 DNA. The three linearized plasmids were
transcribed using an in vitro SP6 transcription kit, and purified using RN easy centrifuge
columns. The transcription products were run on a 1.0% agarose denaturing gel and
stained with ethidium bromide. Lanes 1 and 8: RNA markers; lanes 2 and 3: wt-raf-1
;

mRNA;

l~es 4 ~d 5: Llli( raf-1 IDRNA;~ lanes &-and ? :'· Kn-raf-1 mRNA.
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translated in vivo, three different groups of oocytes were microinjected with a given
mRNA, labelled with 35S-methionine, and then homogenized and the protein extracted.
The protein extracts were electrophoresed on SOS-PAGE and the final results were
viewed via autoradiography techniques. Figure 11 is an autoradiograph of newly
synthesized protein made in mRNA-injected oocytes, as well as in a control group of
oocytes that were microinjected with RNase-free H20. From this autoradiograph it is
evident that the oocytes are translating the microinjected mRNA as is observed by the
definitive dark bands found in the three treatment lanes and not in the control lane. These
bands correspond to the published molecular weights, with wt-raf-1 kinase and KD-raf-1
kinase appearing as proteins of similar size (69 kDa), and ~'-raf-1 kinase appearing as a
smaller protein (40 kDa) which was expected, as it is just the catalytic region of the protein
and not the full-length protein.
B. pHi Measurement in ra[-1 mRNA-injected Oocytes:

1. Oocyte plii for mRNA-injected Oocytes:
Oocytes were preincubated in 14C-DMO for 12 to 14 hours. As shown in Figure
12, oocytes were either left untreated, treated with progesterone (1 µM), or microinjected
with stock concentrations of the three raf-1 mRNA products. Oocytes rnicroinjected with
wt-raf-1 and KD-raf-1 mRNAs coding for inactive proteins did not exhibit an increase in
pHi. Oocytes rnicroinjected with AN'-raf-1 mRNA coding for an active kinase did exhibit
an increase in pHi that appeared similar to the increase in pHi caused by progesterone
stimulation. Based on this unreplicated experiment, it appeared that active AN'-raf-1
caused an increase in pHi. Therefore, the role of active raf-1 kinase was investigated
further.
2. AN'-raf-1 mRNA Dose Response CuIYe:
Oocytes were injected with different concentrations of AN'-raf-1 mRNA, to
determine the lowest concentration of mRNA needed to induce an increase in oocyte pHi
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Figure 11. Electrophoretic analysis of raf-1 mRNA translation in vivo. Oocytes were
microinjected with either H20 (lane 1) as a control, wt-raf-1 mRNA (lane 2),

~N'-raf-1

mRNA (lane 3), or KD-raf-1(lane4) and labelled in OR-2 media with 35S-methionine.
Protein was then extracted and run on a 10% SDS-polyacrylamide gel. The microinjected
mRNA was successfully translated by the oocyte (wt-raf-1 and KD-raf-1
raf-1

= 40 kDa).

= 69 kDa; m·-
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Figure 12. The effects of the three raf-1 mRNAs on oocyte pHj. Oocytes were either left
untreated (Cont.), treated with progesterone (1 µM), ormicroinjected with one of the three
raf-1 mRNAs. Only the AN'-raf-1 mRNA caused an increase in oocyte pHi as well as
GVBD (numbers above the bars show number of oocytes that underwent GVBD out of 20
oocytes).
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that was similar to the increase in pHi induced by progesterone. As shown in Figure 13,
oocytes were microinjected with concentrations of ~N'-raf-1 mRNA ranging from 1.25
ng to 10.0 ng per oocyte. The oocytes were then incubated for 12 to 14 hours to allow for
translation of the mRNA. The results indicated that increasing concentrations of ~N'-raf1 mRNA (and presumably raf-1 protein) induced higher levels of pHi. which appeared to
level off at concentrations greater than 2.5 ng of mRNA per oocyte. Based on these
results, 5.0 ng AN'-raf-1 mRNA per oocyte was the lowest concentration of mRNA that
consistently induced an increase in oocyte pHi that was statistically similar to the increase
in pHi induced by progesterone. All subsequent experiments were conducted using 5.0
ng AN'-raf-1 mRNA per oocyte.
C. The Effect of cAMP on raf-1 Reirulation of the Na±fil± Antiporter:
Recent studies have indicated that elevated levels of cAMP are antagonistic toward
progesterone-induced activation of the Na+/H+ antiporter during oocyte meiotic maturation
(Rezai, 1994). To determine if elevated levels of intracellular cAMP are also antagonistic
toward raf-1 kinase-induced activation of the Na+/H+ antiporter, the following
experiments altering cAMP levels in Xenopus oocytes were performed.
1. Forskolin Activation of Adenylate Cyclase:
Oocytes were treated with forskolin (100 µM) in 14C-DMO or only with 14CDMO for 8 hours. As shown in Figure 14, oocytes from each of the two groups were left
untreated (Cont.), treated with progesterone (l µM), or microinjected with AN'-raf-1
mRNA (5.0 ng/oocyte) and incubated for 12 to 14 hours. The results show that forskolin
significantly inhibited the increase in pHi in progesterone-stimulated oocytes. Forskolin
did not appear to be antagonistic to

~N'-raf-l's

ability to activate the Na+JH+ antiporter.

The pHi in AN'-raf-1 mRNA injected oocytes pre-treated with forskolin was statistically
similar to the pHi in progesterone-treated oocytes without forskolin.
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Figure 13. AN'-raf-1 mRNA dose response curve. Oocytes were either left untreated
(Cont.), treated with progesterone (1 µM), or microinjected with concentrations of AN'raf-1 mRNA ranging from 1.25 to 10.0 ng of mRNA per oocyte. At concentrations of
2.5 ng mRNA per oocyte and higher, the increase in pHi was statistically similar to the
increase in pHi induced by progesterone. Columns with different letters above them are
significantly different from each other using Tulcey's multiple comparison test. The data
are expressed as means± the standard error of the mean, where n=3.
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Figure 14. Forskolin does not appear to be antagonistic to AN'-raf-1 's ability to activate
the Na+/H+ antiporter. Oocytes were incubated in 14C-DMO for 8 hours in the presence
or absence of forskolin (100 µM). The oocytes from both groups were then left untreated
(Cont.), treated with progesterone (1 µM), or microinjected with AN'-raf-1 mRNA (5.0
ng/oocyte). Forskolin treatment significantly blocked the ability of progesterone to
activate the antiporter. The pHi of the oocytes microinjected with the AN'-raf-1 mRNA
did not differ significantly from one another whether they were treated with forskolin or
not. Columns with different letters above them are significantly different from each other
using Tukey's multiple comparison test. The data are presented as means± the standard
error of the mean, where n=3.
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2. 8-Br-cAMP Elevation of Intracellular cAMP Levels:
To verify the forskolin results. a second method of elevating levels of intracellular
cAMP was utilized. Oocytes were treated with 8-Br-cAMP (1.0 mM) in 14C-DMO or
only in 14C-DMO for 8 hours. As shown in Figure 15, oocytes from each of the two
groups were left untreated (Cont.), treated with progesterone (1 µM), or microinjected
with ti.N'-raf-1 mRNA (5.0 ng/oocyte) and incubated for 12 to 14 hours. The results
indicate that 8-Br-cAMP was antagonistic to progesterone's ability to induce an increase in
pHi, but had no significant effect on ti.N'-raf-1 mRNA injected oocytes. These results
confirmed the forskolin experiments. The results from both the forskolin experiments and
the 8-Br-cAMP experiments show that elevated levels of intracellular cAMP are
antagonistic toward a progesterone-induced increase in pHi but have no effect on the
ability of raf-1 kinase to cause an increase in pHj. Therefore, it appears that the cAMP
block is downstream of the progesterone receptor, but upstream of raf-1 kinase in the
protein kinase cascade.

Part IV: MAP kinase kinase
MAP (Mitogen Activated Protein) kinase kinase was the next kinase to be
investigated for its possible role in activation of the Na+/H+ antiporter. This kinase is a
substrate for raf-1 kinase within the protein kinase cascade. as well as the activator of
MAP kinase which is located downstream of MAP kinase kinase within the cascade. To
determine if MAP kinase kinase was responsible for inducing the increase in the oocyte
pHi, the following experiments were conducted.
A. pHi Measurement in MAP klnase kinase Injected Oocytes:
Groups of oocytes were preincubated in 14C-DMO for 3 to 4 hours. As shown in
Figure 16, oocytes were left untreated, treated with progesterone (1 µM), or microinjected
with constitutively active MAP kinase kinase (6.0 ngfoocyte). The oocytes microinjected
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Figure 15. Elevating levels of intracellular cAMP with 8-Br-cAMP does not appear to be
antagonistic to the ability of AN'-raf-1 to activate the Na+/H+ antiporter. Oocytes were
incubated in 14C-DMO for 8 hours in the presence or absence of 8-Br-cAMP (1.0 mM).
The oocytes from both groups were left untreated (Cont.). treated with progesterone (1
µM), or microinjected with AN'-raf-1 mRNA (5.0 ngfoocyte). 8-Br-cAMP significantly
blocked the ability of progesterone to activate the antiporter. The pHi of the oocytes
microinjected with the AN'-raf-1 mRNA did not differ from one another significantly
whether treated with 8-Br-cAMP or not. Columns with different letters above them are
significantly different from each other using Tukey's multiple comparison test. The data
are presented as means± the standard error of the mean, where n=4.
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with constitutively active MAP kinase kinase did not exhibit an increase in pHi as did
those oocytes which were stimulated with progesterone. Oocytes microinjected with
constitutively active MAP kinase kinase maintained levels of pHi that were statistically
similar to the pHi levels found in untreated oocytes (Figure 16).
B. S6 Phos.phorylation as a Confirmation of MAP kinase kinase Activity:

The previous results indicated that constitutively active MAP kinase kinase did not
cause any significant increase in pHi. It has been shown that active MAP kinase kinase
activates MAP kinase, which in tum activates S6 kinase in the protein kinase cascade. To
verify that the MAP kinase kinase microinjected into the oocytes was active,
phosphorylation of the S6 protein on the 40S ribosomal subunit was monitored. Oocytes
were left untreated (Cont.), stimulated with progesterone (1 µM), or microinjected with
constitutively active MAP kinase kinase and labelled in OR-2 medium with 32p_
orthophosphate (100 µCi/ml) for 12 to 14 hours. Oocytes were removed from their
respective treatments and proteins were extracted and run on a SDS-polyacrylamide gel.
Figure 17 shows an autoradiograph comparing the phosphorylation of S6 protein between
the three treatments. S6 protein has a molecular weight of 32,000 Da (14C-methylated
protein markers: lysozyme (14,300 Da), carbonic anhydrase (30,000 Da), ovalbumin
(46,000 Da), bovine serum albumin (69,000 Da), and phosphorylase b (97,400 Da)). S6
was phosphorylated in progesterone-stimulated oocytes, but only weakly phosphorylated
in the constitutively active MAP kinase kinase-microinjected oocytes, and not
phosphorylated at all in the untreated oocytes. This indicates that the constitutively active
MAP kinase kinase that was used was only partially active. Therefore, the lack of effect
of MAP kinase kinase on oocyte pHi seen in Figure 16 must be interpreted with caution.
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Figure 16. MAP kinase kinase does not appear to activate the Na+/H+ antiporter.
Oocytes were incubated in 14C-DMO and were left untreated (Cont.), treated with
progesterone (1 µM), or microinjected with MAP kinase kinase (6.0 ng/oocyte). The pHi
of the oocytes microinjected with MAP kinase kinase was statistically different from the
pHi of the progesterone-treated oocytes, but statistically similar to the pHi of the oocytes
that were left untreated. Columns with different letters above them are significantly
different from each other using Tukey's multiple comparison test. The data are presented
as means± the standard error of the mean, where n=3.

54

1

2

3

32kD

•

Figure 17. Electrophoretic analysis of S6 protein phosphorylation. Oocytes were left
untreated (lane 1), treated with progesterone (1 µM) (lane 2), or microinjected with MAP
kinase kinase (6.0 ng/oocyte) (lane 3) and labelled in OR-2 medium with 32p_
orthophosphate (100 µCi/ml) for 8 hours. Protein was extracted from each of the
treatment groups and run on a 10% SDS-polyacrylamide gel. Phosphorylation of the S6
protein (32,000 kDA) was observed in both the progesterone-treated oocytes and in the
MAP kinase kinase-microinjected oocytes, but not in the untreated oocytes as compared
with 14C-methylated protein markers (lane not shown).

CHAPTER IV

DISCUSSION

One of the physiological events occurring during oocyte meiotic maturation is an
increase in oocyte pHi. Previous studies have shown that this increase in pHi appears to
be the result of the activation of Na+/H+ antiporters present in the plasma membrane of the
oocyte. If the extracellular sodium is replaced with choline chloride, or if amiloride (a
Na+/H+ antiporter inhibitor) is used, the increase in pHi in response to progesterone
stimulation is completely inhibited (Wasserman and Houle, 1984; Stith and Maller, 1985;
Towle et al., 1991; Rezai, 1994). The increase in pHi during Xenopus laevis oocyte
meiotic maturation has been shown to be very important for preparing the egg for
fertilization with the sperm (Houle and Wasserman, 1983). To understand better the role
of pH during these cellular processes, an understanding of how the Na+/H+ antiporter is
regulated during oocyte meiotic maturation needs to be obtained. The Na+/H+ antiporter
in other cell systems is proposed to be regulated by a phosphorylation event. It has been
hypothesized that addition of phosphates induces a conformational change in the structure
of the Na+/H+ antiporter, the result of which is an increased affinity for cytoplasmic
hydrogen ions (Wakabayashi et al., 1992; Borgese et al., 1992). In support of this
hypothesis, investigators have demonstrated that as anti.porter activity increases, there is a
concurrent increase in the phosphorylation of NHEl (Na+/H+ exchanger 1), a
transmembrane glycoprotein of 110 kDa, in fibroblasts, epithelial cells, and blood platelets
(Livne et al.. , 1991; Sardet et al., 1990; Wakabayashi et al., 1992; Grinstein et al., 1992;
Guizouarn et al., 1993).
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In Xenopus oocytes, studies have been pe:rformed to investigate the possible role

of certain protein kinases in regulating the Na+JH+ antiporter. Through use of various
inhibitors and activators, it was determined that Protein Kinase C, Protein Kinase A, and
Calcium-Calmodulin Kinase were not involved in regulation of the Na+/H+ antiporter
(Rezai, 1994). In addition, MPF H-1 kinase was also found not to play a role in
regulating this antiporter (Rezai, 1994). Oocytes stimulated with progesterone undergo
meiotic maturation and a series of protein kinases are phosphorylated, and subsequently
activated, forming a protein kinase cascade. This cascade consists of the following
protein kinases: c-mos kinase, raf-1 kinase, MAP kinase kinase, MAP kinase, and S6
kinase. Preliminary investigations of the possible role of c-mos kinase (the first kinase
within the cascade) in activation of the Na+JH+ antiporter in Xenopus oocytes have been
performed in our laboratory. The results of these studies indicated that high doses of
microinjected c-mos protein can cause an increase in oocyte pHi (Rezai, 1994). It could
not be concluded however, whether c-mos kinase itself or a protein kinase downstream of
c-mos was responsible for the activation of the Na+JH+ antiporter.
In the current study, c-mos kinase, as well as the other protein kinases within the

cascade, were examined for their potential role in regulating the Na+/H+ antiporter during
progesterone-induced oocyte meiotic maturation. The first protein kinase that was
investigated was c-mos kinase. The proto-oncogene product p39 c-mos kinase has been
proposed to be the "initiator" of oocyte maturation. Active c-mos kinase has been shown
to induce GVBD when microinjected into stage VI oocytes in the absence of progesterone
stimulation (Sagata et al., 1989). It was further demonstrated that oocytes pre-treated with
cyclohexirnide (an inhibitor of protein synthesis) and then microinjected with active c-mos
protein underwent GVBD in the absence of progesterone, while oocytes pre-treated with
cycloheximide and then stimulated with progesterone did not undergo GVBD (Yew et al.,
1992). From these experiments it appears that c-mos kinase is the only newly synthesized
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protein needed in the oocyte to trigger GVBD. Preliminary experiments indicated that
high doses of c-mos kinase appeared to play a role in regulating the Na+fH+ antiporter in
Xenopus oocytes (Rezai, 1994). Based on the results from the current study, it appears

that lower doses of c-mos kinase (down to 5 ng of total protein per oocyte) are also
capable of causing an increase in oocyte pHi similar to the increase induced by
progesterone (Figure 3). These results support the earlier conclusion that c-mos kinase
does play a role in activation of the Na+/H+ antiporter inXenopus oocytes.
We do not know what the endogenous level of active c-mos kinase is in
progesterone-stimulated oocytes. The results from experiments performed by other
investigators have shown that low doses of injected c-mos kinase have an effect on GVBD
as well as MAP kinase activity. 2-5 ng c-mos protein injected per oocyte were capable of
inducing an increase in MAP kinase activity and GVBD (Matten et al., 1994). In the
current study, I was unable to determine the exact amount of~ c-mos protein being
injected into each oocyte. Several factors must be taken into consideration when
calculating the amount of c-mos kinase that was injected, such as the actual amount of
active c-mos kinase versus the total amount of c-mos protein present in the preparation.
There is also the problem of leakage of c-mos kinase from the injection wound.
Precautions such as injecting deeper into the oocyte cytoplasm and not withdrawing the
pipette immediately after delivery were taken to minimize this from occurring. Even with
all of these assumptions, I was probably injecting excess active c-mos kinase into the
oocytes.
We know that c-mos kinase appears to be the only newly synthesized protein
needed to trigger GVBD (Yew et al., 1993). A previous study from our laboratory
showed that oocyte protein synthesis is also necessary for the increase in oocyte pHi in
response to progesterone (Rezai, 1994). The results from the current study injecting cmos kinase into cycloheximide-treated oocytes indicate that c-mos kinase appears to be the
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only newly synthesized protein needed to activate the Na+JH+ antiporter (Figure 4).
These results indicated that c-mos kinase plays a role in the activation of the Na+JH+
antiporter. In order to determine if c-mos kinase is activating the antiporter directly or
through the activation of a pre-existing protein kinase located downstream in the cascade
needed to be examined.
During progesterone-induced oocyte meiotic maturation, adenylate cyclase activity
is inhibited, resulting in a decrease in intracellular cAMP and PKA activity (Sadler and
Maller, 1981). It has been shown that if intracellular cAMP is artificially maintained at
elevated levels, steroid-treated oocytes will neither undergo GVBD (Maller and Krebs,
1977; Schorderet-Slatkine et al., 1982; Matten et al., 1994) nor exhibit an increase in pHi
(Rezai, 1994). Artificially elevated levels of intracellular cAMP did not appear to be
antagonistic toward c-mos kinase's ability to activate the Na+{H+ antiporter. Oocytes pretreated with either forskolin (an activator of adenylate cyclase) or 8-Br-cAMP (a cAMP
derivative capable of passing through the oocyte's plasma membrane) and then
microinjected with c-mos kinase exhibited a normal increase in pHi. These results indicate
that the cAMP/PKA block to activating the antiporter is located in the progesteronepathway upstream of c-mos kinase.
The effect of cAMP/PKA on c-mos kinase has been studied in Dr. Vande Woude's
laboratory. They showed that microinjection of the catalytic subunit of PKA inhibited
progesterone-induced translation of c-mos mRNA as well as the activation of downstream
MAP kinase. If, however, the catalytic subunit of PKA was coinjected with active c-mos
protein, MAP kinase was activated (Matten et al., 1994). These results suggest that the
catalytic subunit of PKA acts as a negative regulator during meiotic maturation, blocking
translation of c-mos kinase mRNA, and thus blocking the kinase cascade. Microinjection
of the catalytic subunit of PKA was not performed in the current study, but intracellular
levels of cAMP were artificially elevated. Elevated levels of cAMP should have then
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bound the regulatory subunits of endogenous PKA, freeing the catalytic subunits, yielding
a result similar to injecting the catalytic subunits themselves. By injecting active c-mos
protein, the mRNA translation block by PKA was bypassed. Therefore, the activation of
the Na+JH+ antiporter indicated that the activator is either c-mos kinase or a protein kinase
activated downstream of c-mos.
Ribosomal protein S6 kinase, when activated, is responsible for phosphorylating
the 40S ribosomal protein S6 during oocyte meiotic maturation. S6 kinase is also one of
the most downstream protein kinases within the cascade (Wasserman and Houle, 1984).
Active S6 kinase, however, does not cause activation of the Na+/H+ antiporter when
microinjected into oocytes. A high dose (50 ng of protein per oocyte) of S6 kinase failed
to increase oocyte pHi when microinjected into stage VI oocytes. The activity of the
injected S6 kinase was confirmed by monitoring phosphorylation of ribosome S6 in the
injected oocytes. It can therefore be concluded that S6 protein kinase is not responsible
for the activation of the Na+fH+ antiporter.
Based on the results thus far, the protein kinase that activates the Na+/H+
antiporter may be c-mos kinase, or a kinase downstream of c-mos kinase and upstream of
S6 kinase within the protein kinase cascade. The kinase which immediately follows cmos within the cascade has not yet been determined. It has been shown through use of
oncogenic as well as dominant negative mutant rnRNAs that raf-1 kinase is necessary for
progesterone-induced oocyte meiotic maturation and that it functions downstream of cmos (Muslin et al., 1993). I was unable to obtain raf-1 kinase protein as with c-mos
kinase and S6 kinase. I was, however, able to obtain transcription vectors coding for
three forms of raf-1 kinase: wild-type (wt), constitutively active

(~N'),

and kinase-

deficient (KD). The three vectors were linearized and then transcribed in vitro. All three
raf-1 mRNAs were efficiently translated into protein when injected into oocytes (Figure
11). mRNAs for wt-raf-1 and KD-raf-1 did not induce an increase in pHi or GVBD when
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injected into oocytes, but, AN'-raf-1 mRNA did induce both an increase in pHi and
GVBD in injected oocytes (Figures 12 and 13). Based on these preliminary results, it
would appear that a high dose of AN'-raf-1 mRNA (10 ng per oocyte) was capable of
activating the Na+JH+ antiporter in Xenopus oocytes. Lower doses of AN'-raf-1 mRNA
were also capable of inducing an increase in oocyte pHi. As shown in Figure 13,
concentrations as low as 1.25 ng AN'-raf-1 mRNA per oocyte were able to induce a
significant increase in oocyte pHj, with 2.5 ng mRNA per oocyte and higher inducing an
increase in pHi similar to that caused by progesterone. These concentrations of mRNA
were based on absorbance readings taken of each stock sample. Individual dilutions were
made as needed to obtain the proper concentration of mRNA for injection. The actual
concentration of newly

synthesized~

raf-1 protein could not be determined due to

problems such as leakage of the mRNA out of the injection site, the amount of protein
made in the oocyte, and the activity of the translated protein. Active raf-1 kinase,
however, does appear to play a role in the activation of the Na+JH+ antiporter during
oocyte meiotic maturation. I cannot conclude, however, if raf-1 kinase acts directly on the
Na+/H+ antiporter, or if it is a protein kinase located downstream of raf-1 within the
protein kinase cascade.
Results from experiments carried out in other cell systems propose the following
model for raf-1 kinase activation. Activated ras protein recruits inactive raf-1 kinase to the
plasma membrane of the cell by binding to the amino-terminal region of the raf-1 protein.
Once at the membrane, the complex is anchored by cytoskeletal elements and an unknown
factor unfolds the amino-terminal domain of raf-1 off of the catalytic domain, exposing the
activation sites, serine residues 259 and 621, for phosphorylation. Once raf-1 kinase is
phosphorylated and activated it is released from ras (Stokoe et al., 1994; Daum et al.,
1994; Williams et al., 1994). Based on this proposed model, active raf-1 kinase is located
near the plasma membrane of the cell. This places raf-1 kinase in close proximity to the
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Na+/H+ antiporters allowing raf-1 kinase the opportunity to phosphorylate the Na+/H+
antiporters directly.
Progesterone normally causes a decrease in intracellular levels of cAMP, which, if
artificially maintained elevated, inhibit progesterone's ability to activate the antiporter.
Elevated levels of intracellular cAMP did not appear to be antagonistic toward c-mos
kinase's ability to cause an increase in oocyte pHi. To determine if elevated levels of
intracellular cAMP had any influence on .6N'-raf-1 kinase's ability, similar experiments
were performed. Oocytes pre-treated with forskolin or 8-Br-cAMP and then injected with
t\N'-raf-1 mRNA exhibited a full increase in oocyte pHi (Figures 14 and 15). These
results, along with the results for c-mos kinase, indicate that the cAMP/PKA block is
upstream of both raf-1 kinase and c-mos kinase within the progesterone-stimulated
pathway.
The only known physiological substrate forraf-1 kinase within the protein kinase
cascade is thought to be MAP (Mitogen Activated Protein) kinase kinase. Recently, a
group of researchers have shown that cdc25 phosphatase associates with raf-1 kinase in
mammalian somatic cells and in frog meiotic oocytes (Galaktionov et al., 1995). The
interaction between cdc25 and raf-1 kinase occurred at the carboxy-terminal region of raf1 kinase, which the investigators believe suggests a strong and specific interaction
between the two proteins. Further studies need to be carried out to determine if raf-1
kinase could possibly have multiple substrates.
MAP kinase kinase has been shown to be phosphorylated both in vitro as well as

in vivo by raf-1 kinase (Dent et al., 1992; Huang et al., 1993). Active MAP kinase kinase
in turn activates MAP kinase within the protein kinase cascade. The c-mos kinase and raf1 kinase experiments suggest that the protein kinase responsible for regulating the Na+/H+
antiporter is either raf-1 kinase or a kinase downstream of raf-1 kinase. The S6 kinase
experiments suggest that the Na+fH+ antiporter activating protein kinase is upstream of it,
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therefore, MAP kinase kinase was the next protein kinase to be investigated.
Oocytes which were microinjected with constitutively active MAP kinase kinase
did not exhibit an increase in pHj. As seen in Figure 16, the pHi level of oocytes injected
with constitutively active MAP kinase kinase remained at basal pHi levels (control level)
when compared to the pHi level in progesterone-stimulated oocytes. To accept these
negative results, the activity of the microinjected MAP kinase kinase needed to be
determined. The activity of injected MAP kinase kinase protein can be monitored by
observing phosphorylation of a substrate known to be located downstream of MAP kinase
kinase.

Ribosomal S6 protein was monitored for phosphorylation in oocytes

microinjected with MAP kinase kinase. This level was compared to ribosomal S6 protein
phosphorylation in oocytes stimulated with progesterone. The results indicated that the
constitutively active MAP kinase kinase was only partially active. This may explain why
there was no increase in oocyte pHi in oocytes injected with this protein. Further studies
need to be performed with very active MAP kinase kinase before any conclusion can be
made. Since S6 kinase had no effect on pHj, and MAP kinase kinase had no effect on
pHj, the intermediate kinase, MAP kinase, was not investigated.
Based on the results obtained in this and other studies, the following model of
the role of protein kinases in regulation of the Na+JH+ antiporter is proposed (Figure 18).
Cycloheximide inhibits progesterone's ability to activate the Na+/fl+ antiporter but not that
of injected c-mos protein, indicating that the block is located between the progesterone
receptor and c-mos kinase within the cascade. Cycloheximide is most likely blocking
translation of endogenous c-mos mRNA.

Elevated levels of cAMP/PKA inhibit

progesterone's ability to activate the Na+/fl+ antiporter but not c-mos kinase's or raf-1
kinase's ability to do so. This places the cAMPJPKA block between the progesterone
receptor and c-mos kinase. Data from Dr. Vande Woude's laboratory indicates that
elevated levels of cAMP/PKA block the cytoplasmic polyadenylation and translation of c-
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mos mRNA. Both c-mos kinase and raf-1 kinase can activate the Na+fH+ antiporter while
S6 kinase does not. A previous study has also ruled out MPF (Hl kinase) (Rezai, 1994).
The results from this study indicate that MAP kinase kinase does not activate the Na+/H+
antiporter, but the activity of the protein preparation used is questionable, so further
experimentation with a more active protein preparation are needed to confirm these
findings. Based on the results of this study and the model of raf-1 kinase activation by
translocation to the membrane, it can tentatively be concluded that raf-1 kinase may
directly phosphorylate and activate the Na+JH+ antiporter in Xenopus oocytes during
meiotic maturation.
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Figure 18. A proposed model for the role of protein kinases in the regulation of the
Na+/H+ antiporter in Xenopus laevis oocytes during progesterone-induced meiotic
maturation. Solid arrows indicate direct protein-protein interaction, while dashed arrows
indicate indirect action.
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